Medicare Enrolled
Dr. Charles Turk, M.D.
Urology Physician · Chicago Ridge, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Turk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Turk?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Turk
Dr. Charles Turk is an urology physician in Chicago Ridge, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Turk performed 7,066 Medicare services across 2,915 unique beneficiaries.
Between the years covered by Open Payments, Dr. Turk received a total of $11,538 from 61 pharmaceutical and/or device companies across 389 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Turk is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 17% volume in IL
$11,538 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,066
Medicare services
Top 17% in IL for urology physician
2,915
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~353 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,500 | $2 | $9 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
754 | $34 | $58 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
697 | $2 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
524 | $93 | $225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
459 | $67 | $146 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
334 | $9 | $74 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
319 | $8 | $12 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
188 | $50 | $76 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
116 | $34 | $58 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
116 | $69 | $117 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
84 | $33 | $828 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
83 | $6 | $298 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
83 | $180 | $835 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
76 | $0 | $25 |
| CMV nucleic acid detection test A laboratory test that uses amplified probe techniques to detect cytomegalovirus (CMV) genetic material in a sample. |
58 | $34 | $58 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
58 | $34 | $58 |
| Herpes simplex virus nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the herpes simplex virus. |
58 | $34 | $58 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
58 | $34 | $58 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
58 | $34 | $58 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
49 | $74 | $555 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
48 | $283 | $988 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $125 | $359 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
38 | $45 | $380 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
37 | $11 | $71 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
36 | $67 | $211 |
| Other procedure on male genital system A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories. |
34 | $219 | $1,010 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
33 | $112 | $485 |
| Manual urine cell examination A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells. |
26 | $480 | $1,667 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
21 | $27 | $139 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $48 | $106 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
13 | $162 | $1,120 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
13 | $67 | $249 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
12 | $81 | $1,462 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $132 | $325 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
11 | $582 | $6,282 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
7.1% medium
92.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,538
Total received (2018-2024)
Avg $1,648/year across 7 years
Top 15% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
389
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,375 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$163 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$707
2023
$1,099
2022
$1,449
2021
$1,923
2020
$907
2019
$3,527
2018
$1,925
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Calyxo, Inc.
$112
Sumitomo Pharma America, Inc.
$78
Verity Pharmaceuticals Inc.
$74
COLOPLAST CORP
$65
Janssen Biotech, Inc.
$56
Boston Scientific Corporation
$51
Antares Pharma, Inc.
$45
ABBVIE INC.
$35
Olympus America Inc.
$30
Laborie Medical Technologies Corp.
$24
Novartis Pharmaceuticals Corporation
$23
UROGEN PHARMA, INC.
$23
ConvaTec Inc.
$22
IMMUNITYBIO, INC.
$20
Tolmar, Inc.
$17
Endo USA, Inc.
$17
Myriad Genetic Laboratories, Inc.
$15
Top 3 companies account for 37.4% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$3,189
Astellas Pharma US Inc
$968
Axonics, Inc.
$544
Janssen Biotech, Inc.
$461
Bayer HealthCare Pharmaceuticals Inc.
$457
Antares Pharma, Inc.
$415
Boston Scientific Corporation
$403
Myovant Sciences Inc.
$395
AbbVie, Inc.
$288
Verity Pharmaceuticals Inc.
$282
Sumitomo Pharma America, Inc.
$268
Endo Pharmaceuticals Inc.
$246
Teleflex LLC
$233
BOSTON SCIENTIFIC CORPORATION
$233
PFIZER INC.
$225
AbbVie Inc.
$190
TOLMAR Pharmaceuticals, Inc.
$180
Olympus America Inc.
$177
Allergan Inc.
$171
SRS Medical Systems, Inc.
$143
Dendreon Pharmaceuticals LLC
$140
ABBVIE INC.
$139
180 Medical, Inc.
$131
Allergan, Inc.
$112
Calyxo, Inc.
$112
Laborie Medical Technologies Corp.
$94
ConvaTec Inc.
$89
UROVANT SCIENCES INC
$87
Bayer Healthcare Pharmaceuticals Inc.
$86
AngioDynamics, Inc.
$75
Photocure Inc
$74
Blue Earth Diagnostics Limited
$69
COLOPLAST CORP
$65
Merck Sharp & Dohme LLC
$64
Coloplast Corp
$59
Clarus Therapeutics Inc.
$53
Rochester Medical Corporation
$52
Ambu Inc.
$49
Egalet US Inc
$38
Progenics Pharmaceuticals, Inc.
$37
Supernus Pharmaceuticals, Inc.
$37
Tolmar, Inc.
$31
Merck Sharp & Dohme Corporation
$29
Myriad Genetic Laboratories, Inc.
$29
Amgen Inc.
$26
Retrophin, Inc.
$25
UroGen Pharma, Inc.
$24
Novartis Pharmaceuticals Corporation
$23
Zyla Life Sciences
$23
UROGEN PHARMA, INC.
$23
Aytu BioScience, Inc
$22
IMMUNITYBIO, INC.
$20
Otsuka America Pharmaceutical, Inc.
$18
Endo USA, Inc.
$17
Pacira Pharmaceuticals Incorporated
$17
Medtronic, Inc.
$16
Avadel Specialty Pharmaceuticals, LLC
$15
Mission Pharmacal Company
$15
ABC Home Medical Supply, Inc.
$15
Metuchen Pharmaceuticals
$12
Sagent Pharmaceuticals, Inc.
$12
Top 3 companies account for 40.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ANKTIVA · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · Bulkamid · CVAC ASPIRATION SYSTEM · Cysview · EDEX · ELIGARD · ERLEADA · EXPAREL · Erleada · GEMTESA · GENERAL BPH · GENERAL THERAPIES · GENERAL - BPH · GENERAL BPH · GENTLECATH · GentleCath · Glydo · GreenLight XPS · INTERSTIM · JATENZO · JELMYTO · JYNARQUE · KEYTRUDA · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · NanoKnife · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · PLUVICTO · PREZCOBIX · PROLARIS · PROVENGE · PYLARIFY · REZUM · ROCHESTER MAGIC3 · Rezum Generator · SOLTIVE · SPEEDICATH · SPRIX · SUTENT · Self-Cath · SpeediCath · Stendra · TLANDO · TOVIAZ · Trelstar · UROLIFT · Uribel · UroCuff · UroLift · UroLift System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
321
Per 100K population
6.2
County median income
$81,797
Nearest hospital
ADVOCATE CHRIST HOSPITAL & MEDICAL CENTER
1.6 mi
1.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Turk is a clinical cardiology specialist, with above-average Medicare volume (top 17% in IL), with low-engagement industry engagement in the top 15% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Turk experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Turk performed 2,500 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Turk receive payments from pharmaceutical companies?
Yes. Dr. Turk received a total of $11,538 from 61 companies across 389 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Turk's costs compare to other urology physicians in Chicago Ridge?
Dr. Turk's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Turk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Chicago Ridge
Browse urology physicians in Chicago Ridge ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology